-transparent.png){kind=logo}
Glycogen synthase kinase 3 (GSK-3), an element of the Wnt signalling pathway, plays a key role in numerous cellular processes including cell proliferation, embryonic development, and neuronal functions. It is directly involved in diseases such as cancer (by controlling apoptosis and the levels of beta-catenin and cyclin D1), Alzheimer's disease (tau hyperphosphorylation), and diabetes (as a downstream element of insulin action, GSK-3 regulates glycogen and lipid synthesis). We describe here a rapid and efficient method for the purification of GSK-3 by affinity chromatography on an immobilized fragment of axin. Axin is a docking protein which interacts with GSK-3ss, beta-catenin, phosphatase 2A, and APC. A polyhistidine-tagged axin peptide (residues 419-672) was produced in Escherichia coli and either immobilized on Ni-NTA agarose beads or purified and immobilized on CNBr-activated Sepharose 4B. These "Axin-His6" matrices were found to selectively bind recombinant rat GSK-3 beta and native GSK-3 from yeast, sea urchin embryos, and porcine brain. The affinity-purified enzymes displayed high kinase activity. This single step purification method provides a convenient tool to follow the status of GSK-3 (protein level, phosphorylation state, kinase activity) under various physiological settings. It also provides a simple and efficient way to purify large amounts of active recombinant or native GSK-3 for screening purposes.
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
July 2007,
Protein expression and purification,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
December 1977,
Thrombosis research,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
December 1980,
The Journal of biological chemistry,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
March 1992,
BioTechniques,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
November 1996,
European journal of biochemistry,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
August 1987,
Infection and immunity,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
August 1981,
Plant physiology,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
June 2020,
Cold Spring Harbor protocols,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
January 2015,
Biotechnology and applied biochemistry,
A Primot, and
B Baratte, and
M Gompel, and
A Borgne, and
S Liabeuf, and
J L Romette, and
E H Jho, and
F Costantini, and
L Meijer
July 1995,
Analytical biochemistry,
